Ocumension Therapeutics (1477.HK)

HKD 5.55

(0.36%)

Operating Expenses Summary of Ocumension Therapeutics

Ocumension Therapeutics's latest annual operating expenses in 2023 was 144.36 Million CNY , down -0.99% from previous year.
Ocumension Therapeutics's latest quarterly operating expenses in 2023 FY was 545.7 Million CNY , down -0.99% from previous quarter.
Ocumension Therapeutics reported a annual operating expenses of 551.14 Million CNY in annual operating expenses 2022, up 30.45% from previous year.
Ocumension Therapeutics reported a annual operating expenses of 422.47 Million CNY in annual operating expenses 2021, down -15.37% from previous year.
Ocumension Therapeutics reported a quarterly operating expenses of 130.69 Million CNY for 2023 Q4, down 0.0% from previous quarter.
Ocumension Therapeutics reported a quarterly operating expenses of 545.7 Million CNY for 2023 FY, down -0.99% from previous quarter.

Annual Operating Expenses Chart of Ocumension Therapeutics (2023 - 2018)

Historical Annual Operating Expenses of Ocumension Therapeutics (2023 - 2018)

Year	Operating Expenses	Operating Expenses Growth
2023	144.36 Million CNY	-0.99%
2022	551.14 Million CNY	30.45%
2021	422.47 Million CNY	-15.37%
2020	499.19 Million CNY	213.71%
2019	159.12 Million CNY	221.81%
2018	49.44 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2023 Q2	141.52 Million CNY	0.0%
2023 Q4	130.69 Million CNY	0.0%
2023 FY	545.7 Million CNY	-0.99%
2023 Q1	141.52 Million CNY	-3.02%
2023 Q3	130.69 Million CNY	-7.66%
2022 Q1	119.85 Million CNY	6.06%
2022 Q2	119.85 Million CNY	0.0%
2022 Q4	145.93 Million CNY	0.0%
2022 Q3	145.93 Million CNY	21.76%
2022 FY	551.14 Million CNY	30.45%
2021 Q1	48.62 Million CNY	-82.21%
2021 FY	422.47 Million CNY	-15.37%
2021 Q4	113 Million CNY	0.0%
2021 Q3	113 Million CNY	132.41%
2021 Q2	48.62 Million CNY	0.0%
2020 Q3	273.37 Million CNY	-68.79%
2020 Q2	875.86 Million CNY	0.0%
2020 FY	499.19 Million CNY	213.71%
2020 Q1	875.86 Million CNY	61.96%
2020 Q4	273.37 Million CNY	0.0%
2019 Q3	540.78 Million CNY	336.27%
2019 FY	159.12 Million CNY	221.81%
2019 Q4	540.78 Million CNY	0.0%
2019 Q1	123.95 Million CNY	0.0%
2019 Q2	123.95 Million CNY	0.0%
2018 FY	49.44 Million CNY	0.0%

Peer Operating Expenses Comparison of Ocumension Therapeutics

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	55.587%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	80.472%